• BTC $10,284.28 (-1.42%)
  • ETH $215.78 (-2.59%)
  • MARKET CAP $281B
  • ICOs 4,234


ENDED 221 views
Total Rate

Future of Medicine Online

MediConnect is the only blockchain solution intended to revolutionize the use of medication in the UK. It will prevent the over-prescribing to patients of medication from multiple pharmacies, reduce addiction, provide traceability of drugs from manufacturers, wholesalers, prescribers and pharmacies all the way through to patients. This will enable the removal of false medicines and the easy recall of drugs within the Pharma system. The Safety Net for Patients, Prescribers, Pharmacies and Drug Manufacturers: With all the regulatory bodies within the Pharmacy sector recognizing and concerned about the growing issue of over-prescribing of prescription medication online, MediConnect can offer a solution to this growing problem almost immediately. Prescribers & pharmacies using MediConnect will have the confidence that by using our blockchain solution, the misuse and over-prescribing of prescription medication to potential addicts – who would normally shop around online for medication – will be eliminated. Patients will be given the assurance that the medication they are being prescribed is genuine and from a licensed manufacturer, prescriber and pharmacy that is using a gold-standard solution to help improve their own duty of care.
Website: Visit
White paper: Read
Pre-sale Time: 6 Feb, 2019 - 16 Feb, 2019
ICO Time: 20 Feb, 2019 - 3 Apr, 2019
Whitelist/KYC: Whitelist
Country: UK
Token Info
Ticker: MEDI
Pre-sale Price: 0,1 USD
ICO Price: 0,1 USD
Social Media
  • 1

    Q1 2018

    Conceived Idea and scoped out requirements of a Prescription Drug Addiction Database.

  • 2

    Q2 2018

    Agreed blockchain platform partnership with Stratis.

  • 3

    Q3 2018

    Presented idea of a regional trial of East Midlands Pharmacies with newly formed Nottingham Addiction Safeguarding Committee.

  • 4

    Q4 2018

    Jason Timms appointed chair of the official Prescription Drug Addiction (PDA) Working Group with the BBFA to tackle over prescribing, drug recalls, counterfeit drug reduction. Agreed contract start date with ASC Nottingham for Q2 2019 and the onboarding of 2 Pharmacies to MediConnect. Attended all Chairperson Meeting of the BBFA working groups to look at collaborative opportunities of the PDA on legal, identity, master data, assurance and Cybersecurity working groups.

  • 5

    Q1 2019

    ICO Public Sale. PDA Working Group meeting – Invites to attend to CQC, MHRA, GPhC, LPC, Pharma wholesale and retail industry.

  • 6

    Q2 2019

    Commence contract with the ASC to support the Nottingham Trial and UK roll out programme. Tower Pharmacy & UK Meds will be first 2 Pharmacies on the ASC blockchain solution from MediConnect. 6 other Pharmacies will be integrated, including 1 NHS Hospital outpatient dispensing pharmacy.

  • 7

    Q3 2019

    Collaboration with Local Pharmacy Groups and membership committee to inform on pilot and expand reach to 20 further pharmacies in Nottingham, Derby & Leicester. Partnership with Pharmacy Wholesaler – implementation of drug recall and counterfeit medication system.

  • 8

    Q4 2019

    Publish trial research and outcomes – present at PDA meeting to CQC, MHRA. GPhC, LPC and Industry.

  • 9

    Q1 2020

    The MediConnect platform will demonstrate an improved duty of care and detection that will see a reduction in pharmacy insurance for Pharmacies.

  • 10

    Q2 2020

    Will see the recruitment of 500 UK Pharmacies join MediConnect through the expansion of the ASC membership in the UK.

  • 11

    Q3 2020

    Aim for MediConnect to be the Industry standard solution for traceability of drugs for recall and counterfeit medication detection.

  • 12

    Q4 2020

    The ASC achieves it’s goal of UK Pharmacies required to be members of the ASC and the MediConnect platform is used by all UK pharmacies

MediConnect is a safety net for patients, prescribers, pharmacies and drug manufacturers. Our vision is to become the gold standard blockchain solution approved by the Pharmacy and Medicine regulators for the prevention of obtaining multiple prescriptions from online and offline pharmacies.

In addition, through the MediConnect blockchain solution the identification of counterfeit and recalled drugs and their distribution can be prevented. Protecting patients and the industry whilst ensuring potentially huge cost savings for the Pharma world.

After seeing the impact of the oversupply of medication, via the National Health Service (NHS) and private routes, in January 2018 two online pharmacy owners and a superintendent pharmacist, discussed what could be done to stop these patients buying across multiple online and offline pharmacies.

Put this code to your website

Width: 420px-Height: 210px
comments powered by Disqus
Hot and trending ICOs
This website is using cookies. More info.